X

gutNEWS.org

A source for healthcare professionals to access the latest data and information on the diagnosis, treatment and management of patients with gut related disorders

Video series

A series of video presentations exploring information relevant to gastroenterologists, including summaries from key conferences.

Let's talk about irritable bowel syndrome (IBS)
Professor David S. Sanders 

Professor Sanders highlights that many patients presenting with irritable bowel syndrome (IBS) have underlying diseases. He explores why  patients do not always benefit from having treatments that are well recognised for IBS and notes that some patients may in fact have another diagnosis, disease or disorder.

Read Transcript >

Hello, my name is David Sanders. I’m the Professor of Gastroenterology here at the Royal Hallamshire Hospital and with the University of Sheffield, United Kingdom. What I’d like to talk to you today is irritable bowel syndrome, and the question I would like to ask is, Is this a disorder where an extensive workup is necessary?

If you are a cinema lover as I am, then you will know that in ‘The Matrix’, Morpheus offers a choice to Keanu Reeves: Would he like the ‘blue pill’ or the ‘red pill’? and I ask the same question of you. The blue pill allows you to continue in your current practice in the management of patients with IBS-type symptoms, but the red pill may change how you see things and change your practice forever.

Now, we all know that the Rome Criteria are supposed to be used to make a positive diagnosis for IBS patients without extensive investigations, but let me ask you this question: Is there anything else in your practice, as a gut doctor that makes you come to a diagnosis without further tests? I know that’s surprising but it’s something I’d really like you to think about. Of course, IBS is a diagnosis and there are many patients who benefit from having that diagnosis and there is an extensive pathophysiological mechanism as I’ve shown on this slide. But what’s always troubled me is, Could there be patients lurking within there who have IBS-type symptoms - and I’m very specific in how I differentiate this – who, in fact, have another diagnosis, disease or disorder?

Why would I think that? Well, can I ask you: Why is it that your patients do not always benefit from having treatments that are well recognised for IBS? Why is there such a high placebo response? Is it because they are a very mixed group of patients, a heterogeneous group of patients, and that there are other diseases lurking within this group? Now, I appreciate that I am a heretic and I’m giving you a different view but in the next few slides I will summarise my perspective.

When you really look at the data and look at the publication stream out there, there are a number of studies looking at different conditions: Coeliac disease, exocrine pancreatic insufficiency, bile acid diarrhoea, microscopic colitis and small bowel bacterial overgrowth, and if you investigate your patients (and I strongly urge you to do so) who present to your outpatient clinic with unselected symptoms of an IBS-type nature, then you will discover all of these diagnosis within, and it will leave you with a group of patients who truly do have IBS and I firmly believe that those are the ones who will benefit from the right therapeutic approach.

So I ask you again: Would you like the blue pill, or the red pill?

Mechanism of bile acid diarrhoea
Professor Julian R.F. Walters

Professor Walters explores the classification of different causes of bile acid diarrhoea (BAD). Professor Walters describes the normal entrohepatic circulation of bile salts and what occurs when the system does not function correctly. 

Read More

 

How common is bile acid diarrhoea (BAD)?
Professor David S. Sanders 

Professor Sanders argues that many patients presenting with irritable bowel syndrome (IBS) have underlying diseases. He explores a series of studies that suggest approximately 25% of patients presenting with IBS symptoms have BAD as the underlying cause. 

Read More

 

Bile acid diarrhoea: who should I test 
Professor David S. Sanders

Professor Sanders discusses which clinical scenarios might warrant investigation for bile acid diarrhoea (BAD) and how this could improve treatment for these patients.

Read More

Pathophysiology of bile acid diarrhoea
Professor Julian R.F. Walters

Professor Julian Walters discusses the pathophysiology of bile acid diarrhoea with regards to ileal disease and ileal resection; he also discusses primary idiopathic bile acid malabsorption diarrhoea.

Read More

 

Irritable bowel syndrome (IBS) is a disorder of exclusion: An extensive diagnostic work-up is necessary
Professor David S. Sanders 

Professor Sanders highlights that many patients presenting with irritable bowel syndrome (IBS) have underlying diseases. He explores why patients do not always benefit from having treatments that are well recognised for IBS and notes that some patients may in fact have another diagnosis, disease or disorder.

Read More

 

Are you a healthcare professional?

This educational website is developed by GE Healthcare for educational purposes. The information contained within this website is intended for healthcare professionals. By entering this website you are confirming that you are a healthcare professional.

Enter the website

This link opens another website that is not under the review or control of GE Healthcare Ltd and, as such, the company does not endorse the content, its accuracy, or any practices or standards contained within it.